789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer

• Takuya Osada,
• Erica Browning,
• Erika Crosby,
• Hiroshi Nagata,
• Melinda Telli,
• Chaitanya Acharya,
• Irene Wapnir,
• Kaitlin Zablotsky,
• Reneta Hermiz,
• Lauren Svenson,
• Donna Bannavong,
• Kellie Malloy,
• David Canton,
• Christopher Twitty,
• Herbert Lyerly

Affiliations

Takuya Osada

Aff2 grid.26009.3d0000000419367961Duke University Durham NC USA

Erica Browning

Aff164 OncoSec Medical Inc. San Diego CA USA

Erika Crosby

1Duke University, Durham, NC, USA

Hiroshi Nagata

1Duke University, Durham, NC, USA

Melinda Telli

2Stanford University, Stanford, CA, USA

Chaitanya Acharya

1Duke University, Durham, NC, USA

Irene Wapnir

2Stanford University, Stanford, CA, USA

Kaitlin Zablotsky

2Stanford University, Stanford, CA, USA

Reneta Hermiz

3OncoSec Medical Inc., San Diego, CA, USA

Lauren Svenson

3OncoSec Medical Inc., San Diego, CA, USA

Donna Bannavong

3OncoSec Medical Inc., San Diego, CA, USA

Kellie Malloy

3OncoSec Medical Inc., San Diego, CA, USA

David Canton

3OncoSec Medical Inc., San Diego, CA, USA

Christopher Twitty

3OncoSec Medical Inc., San Diego, CA, USA

Herbert Lyerly

1Duke University, Durham, NC, USA